Clinical trials
Breast clinical trials
Below are recruiting breast clinical trials, each written for real people, not researchers. We’re tracking 2,627 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07454499Recruiting
Symptom monitoring and health for women on hormone therapy for breast cancer
This trial tests a mobile health program to help women manage symptoms and stay healthy while taking hormone therapy (like tamoxifen or anastrozole) for early-stage breast cancer. It involves using a smartphone app and an electronic pill bottle to track your health and medication.
Philadelphia, PennsylvaniaAges 18 years+ - NCT07460297Enrolling by invitation
Antibiotic and iodine for infection prevention in breast reconstruction
This trial tests if a combination of a pseudomonas bacteria injection and an iodine solution can help prevent infections in women having immediate breast reconstruction with implants after mastectomy or breast-conserving surgery.
Shenyang, LiaoningAges 18 years+ - NCT07455955RecruitingPhase 2
Custom anti-nausea treatment based on your genes
This trial tests if giving anti-nausea drugs based on your genetic makeup can better prevent vomiting and nausea from chemotherapy for early breast cancer. You will receive a personalized regimen tailored to your pharmacogenetic profile.
Hong KongAges 18–74 - NCT06796166Recruiting
AI-supported education for women having mastectomy
This study tests if education supported by artificial intelligence (AI) helps women recover better after breast removal surgery. If you're having a mastectomy, you may be able to join.
Istanbul, BakirköyAges 18 years+ - NCT07448558Recruiting
Tailored exercise for breast cancer joint pain
This trial tests if a personalized exercise program can reduce joint and muscle pain caused by aromatase inhibitors in breast cancer patients. It may help you feel better during your hormone therapy.
BangkokAges 18 years+ - NCT07447050RecruitingPhase 2
Riluzole to Prevent Chemo-Related Cognitive Problems
This pilot study tests whether the drug riluzole can help prevent the thinking and memory problems (often called 'chemobrain') that some people experience during chemotherapy. If you are about to start a chemo regimen containing an anthracycline or platinum drug, you may be able to join.
Orange, CaliforniaAges 18 years+ - NCT07447440Recruiting
Study on natural fats linked to obesity-related diseases
This trial explores how certain natural fats in the body might affect diseases linked to obesity, such as breast cancer. It aims to see if these fats can reduce inflammation and improve health.
Pamplona, NavarreAges Any age - NCT07446868Recruiting
Comparing two nerve blocks for pain after mastectomy
This trial compares two nerve-block techniques (SPSIP and ESPB) to see which one provides better pain relief after breast cancer surgery. The goal is to reduce pain and improve recovery after a modified radical mastectomy.
Cairo, Cairo GovernorateAges 18–65 - NCT03740503Recruiting
Study genes in people who respond unusually to treatment
This study looks at stored tumor samples to understand why some people respond much better or much worse than expected. The goal is to learn what the tumor’s genes might be telling doctors about response to treatment.
Toronto, OntarioAges 18 years+ - NCT06106529RecruitingPhase 3
Reducing hot flashes in women on hormone therapy for breast cancer
This trial tests a new approach to reduce hot flashes in women taking hormone therapy for breast cancer. You may be able to join if you have at least 14 hot flashes a week and are not taking certain other treatments.
Delft, South HollandAges 18 years+ - NCT07436078Recruiting
Genetic testing study for African American cancer survivors
This study offers genetic testing and counseling to African American cancer survivors. It aims to see if a culturally tailored approach helps more people understand their cancer risk and get the testing they need.
Detroit, MichiganAges 20–79 - NCT07436312Recruiting
Effect of ultra-processed foods on cancer risk in high-risk people
This trial looks at whether eating less ultra-processed foods can lower cancer risk in people who are already at high risk for cancer. It is part of a larger program called Interception that helps monitor and reduce cancer risk.
AvignonAges 18 years+ - NCT06489665Recruiting
Testing a clearer mammogram for breast imaging
This study tests a new type of mammogram that might give clearer pictures of breast tissue. It is for women who are either scheduled for breast surgery or getting a regular mammogram.
Zurich, Canton of ZurichAges 18 years+ - NCT07432633RecruitingPhase 1/Phase 2
Imaging scan to detect cancer-linked protein in several tumor types
This trial tests a new PET scan tracer that targets a protein found on certain cancer cells. It may help doctors better see and understand tumors in people with colorectal, gastric, pancreatic, lobular breast, or ovarian cancer.
Dallas, TexasAges 18–80 - NCT06786026RecruitingPhase 2
Drug combo plus chemotherapy for first-line advanced triple-negative breast cancer
This trial tests whether adding an experimental immunotherapy drug (QL1706) with or without bevacizumab to standard chemotherapy can help people with advanced triple-negative breast cancer that hasn't been treated yet. It aims to improve outcomes for patients who have already had earlier treatment but whose cancer has come back or spread.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07426822RecruitingPhase 2
Preventing Rash and Diarrhea with Capivasertib for Breast Cancer
This trial tests whether giving a combination of the drugs capivasertib and fulvestrant, along with medicines to prevent rash and diarrhea, can help treat hormone receptor-positive breast cancer that has a PIK3CA, AKT1, or PTEN change. It's for people whose cancer has spread or is locally advanced and can't be removed with surgery.
New Haven, ConnecticutAges 18 years+ - NCT07429487Recruiting
Smartwatch activity tracking for fatigue after chemo
This study uses a smartwatch to track your physical activity and see if it helps reduce tiredness after finishing chemotherapy. It is for people who finished treatment for certain cancers less than 3 months ago.
NiceAges 18–75 - NCT07426809Recruiting
A study to improve lumpectomy surgery with real-time imaging
This study tests a new imaging tool that helps surgeons see cancer margins in real time during a lumpectomy, aiming to reduce the need for a second surgery. It is for women with early-stage breast cancer who are planning a lumpectomy.
Beaumont, DublinAges 18 years+ - NCT07434128RecruitingPhase 2
Breast density medication and mammogram clarity study
This study tests whether taking a medicine called ulipristal acetate before a mammogram can improve the breast density seen on the scan, possibly making cancer easier to detect.
Portland, OregonAges 18–50 - NCT06813456Recruiting
Improving HER2 detection in breast cancer with new testing method
This trial studies a more precise way to measure HER2 levels in breast cancer tissue. It may help identify patients whose cancer is HER2-low or HER2-zero, so they can get more targeted treatment.
Bologna, BolognaAges 18 years+ - NCT06773143Recruiting
Esketamine for sleep quality during breast cancer chemo
This trial tests whether a low dose of esketamine can improve sleep quality in women with breast cancer who are receiving neoadjuvant chemotherapy. If you have trouble sleeping during treatment, this study may find a new way to help.
Nanjing, JiangsuAges 18–65 - NCT07422870Recruiting
Registry for granulomatous mastitis
This study is creating a registry (a database) for people with a rare inflammatory breast condition called granulomatous mastitis. It aims to learn more about the disease and how it affects people, without testing any new treatments.
Düsseldorf, North Rhine-WestphaliaAges 18 years+ - NCT07424547RecruitingPhase 1
Study of SYS6043 for advanced or metastatic solid tumors
This trial tests a new study drug (SYS6043) for people with advanced or metastatic solid tumors that have not responded to or are not candidates for standard therapies. The drug targets a protein called B7-H3 on cancer cells to help stop tumor growth.
Plantation, FloridaAges 18 years+ - NCT07416630Recruiting
Web app for tracking radiation side effects in cancer patients
This study is testing a web-based app to help track side effects from radiation therapy in people with gynecologic, urologic, or breast cancer. If you join, you would use the app on your phone or computer to report how you're feeling, which may help your care team better manage your symptoms.
LjubljanaAges 18 years+
Hear when a new Breast trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for breast?
- Yes. Clin2 currently lists 2,627 recruiting breast studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a breast trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a breast trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.